BUDGET IMPACT ANALYSIS OF NIRAPARIB AND OLAPARUB AS MAINTENANCE THERAPY FOR PLATINUM SENSITIVE, RECURRENT OVARIAN CANCER IN THE US

被引:0
|
作者
Wu, L. [1 ]
Zhong, L. [1 ]
机构
[1] Texas A&M Univ, College Stn, TX USA
关键词
D O I
10.1016/j.jval.2018.04.132
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCN54
引用
收藏
页码:S22 / S22
页数:1
相关论文
共 50 条
  • [1] Budget impact analysis of niraparib and olaparib for maintenance treatment of platinum-sensitive, recurrent ovarian cancer in the US
    Wu, Lei
    Zhong, Lixian
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (02) : 187 - 195
  • [2] Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
    Mirza, M. R.
    Monk, B. J.
    Herrstedt, J.
    Oza, A. M.
    Mahner, S.
    Redondo, A.
    Fabbro, M.
    Ledermann, J. A.
    Lorusso, D.
    Vergote, I.
    Ben-Baruch, N. E.
    Marth, C.
    Madry, R.
    Christensen, R. D.
    Berek, J. S.
    Dorum, A.
    Tinker, A. V.
    du Bois, A.
    Gonzalez-Martin, A.
    Follana, P.
    Benigno, B.
    Rosenberg, P.
    Gilbert, L.
    Rimel, B. J.
    Buscema, J.
    Balser, J. P.
    Agarwal, S.
    Matulonis, U. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (22): : 2154 - 2164
  • [4] Budget impact of niraparib as maintenance treatment in recurrent ovarian cancer following platinum-based chemotherapy
    Neeser, Kurt
    O'Neil, William M.
    Stern, Lee
    Harrow, Brooke
    Travers, Karin
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (08) : 577 - 587
  • [5] Cost-effectiveness analysis of niraparib maintenance therapy in Chinese patients with platinum-sensitive recurrent ovarian cancer
    Qiu, Yijin
    Zha, Jingkai
    Ma, Aixia
    Zhou, Ting
    GYNECOLOGIC ONCOLOGY, 2023, 174 : 175 - 181
  • [6] Cost-effectiveness analysis of olaparib and niraparib as maintenance therapy for women with recurrent platinum-sensitive ovarian cancer
    Leung, John Hang
    Lang, Hui-Chu
    Wang, Shyh-Yau
    Lo, Hsueh Fang
    Chan, Agnes L. F.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (03) : 489 - 496
  • [7] BUDGET IMPACT FOR OLAPARIB MAINTENANCE THERAPY FOR BRCA-MUTATED PLATINUM SENSITIVE RECURRENT OVARIAN CANCER IN PANAMA
    Torres Toala, F. G.
    Solorzano, J.
    Baldi, J.
    Castillo-Fernandez, O.
    VALUE IN HEALTH, 2018, 21 : S22 - S22
  • [8] BUDGET IMPACT FOR OLAPARIB MAINTENANCE THERAPY FOR BRCA-MUTATED PLATINUM SENSITIVE RECURRENT OVARIAN CANCER IN PERU
    Torres Toala, F. G.
    Solorzano, J.
    Baldi, J.
    VALUE IN HEALTH, 2018, 21 : S22 - S22
  • [9] BUDGET IMPACT ANALYSIS FOR OLAPARIB MAINTENANCE THERAPY FOR BRCA-MUTATED PLATINUM SENSITIVE RECURRENT OVARIAN CANCER IN COSTA RICA
    Torres Toala, F. G.
    Solorzano, J.
    Baldi, J.
    Landaverde, D.
    Gonzalez, I
    VALUE IN HEALTH, 2018, 21 : S21 - S21
  • [10] Cost-Effectiveness of Niraparib and Olaparib as Maintenance Therapy for Patients with Platinum-Sensitive Recurrent Ovarian Cancer
    Zhong, Lixian
    Anh Thu Tran
    Tomasino, Taylor
    Nugent, Elizabeth
    Smith, Judith A.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (12): : 1219 - 1228